414 related articles for article (PubMed ID: 6457135)
1. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
2. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
Littlefield JL; Rudd TG
J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
[TBL] [Abstract][Full Text] [Related]
6. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.
Molloi S; Mazess R; Bendsen H; Wilson M
Calcif Tissue Int; 1989 May; 44(5):322-9. PubMed ID: 2496903
[TBL] [Abstract][Full Text] [Related]
7. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
[TBL] [Abstract][Full Text] [Related]
8. Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication.
Smith ML; Martin W; Fogelman I; Bessent RG
J Nucl Med; 1983 Mar; 24(3):208-11. PubMed ID: 6402571
[TBL] [Abstract][Full Text] [Related]
9. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
[TBL] [Abstract][Full Text] [Related]
10. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
[TBL] [Abstract][Full Text] [Related]
11. Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.
Smith ML; Fogelman I; Ralston S; Boyce BF; Boyle IT
Metab Bone Dis Relat Res; 1984; 5(4):167-70. PubMed ID: 6429474
[TBL] [Abstract][Full Text] [Related]
12. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y
Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
[No Abstract] [Full Text] [Related]
13. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
Armas R; Neumann R; Goldsmith SJ
J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
[TBL] [Abstract][Full Text] [Related]
14. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat.
Watt I; Hill P
Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174
[TBL] [Abstract][Full Text] [Related]
16. Age-related alterations in skeletal metabolism--24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication.
Fogelman I; Bessent R
J Nucl Med; 1982 Apr; 23(4):296-300. PubMed ID: 6802938
[TBL] [Abstract][Full Text] [Related]
17. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
18. A radiopharmaceutical and clinical comparison of 99mTc-Sn-hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate.
Silberstein EB
Radiology; 1980 Sep; 136(3):747-51. PubMed ID: 6773104
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.
Rudd TG; Allen DR; Smith FD
J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422
[TBL] [Abstract][Full Text] [Related]
20. Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera.
Martin W; Fogelman I; Bessent RG
J Nucl Med; 1981 Jun; 22(6):542-5. PubMed ID: 6785399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
